ProGenis Pharmaceuticals is delighted to announce the appointment of Professor Bu Yeap as its new Clinical Advisor for Metabolic Diseases.… Read More »ProGenis Pharmaceuticals Welcomes Professor Bu Yeap as Clinical Advisor for Metabolic Diseases

A new chapter in groundbreaking health research has begun with the official launch of ProGenis Pharmaceuticals, a cutting-edge pharmaceutical startup set… Read More »WA Pharma Startup ProGenis Pharmaceuticals Aims to Revolutionise Diabetes and Rare Disease Treatment

In an exciting new collaboration, ProGenis Pharmaceuticals has entered into a Patent Assignment Agreement with Murdoch University, Western Australia, to… Read More »ProGenis Pharmaceuticals Partners with Murdoch University to Develop Groundbreaking Treatment for Duchenne Muscular Dystrophy

ProGenis Pharmaceuticals, a leader in innovative scientific solutions, is proud to announce the appointment of Dr. Sudhir Agrawal as the… Read More »ProGenis Pharmaceuticals Welcomes Dr. Sudhir Agrawal as its Chair of the Scientific Advisory Board